Press Releases

April 1, 2008
Accelr8 and BD Agree on Terms for Technology Development Program

Companies agree on terms for joint development and licensing option for the BACcel™ rapid diagnostics platform.

January 3, 2008
Accelr8 Announces Research Programs in Two Leading Medical Research Centers

Agreements for collaborative studies on BACcel® rapid analysis methods for identifying deadly antibiotic resistance mechanisms in “superbugs.”

December 13, 2007
BD Acquires Right to Negotiate Business Relationship for Accelr8's BACcel® Rapid Diagnostics Technology

November 23, 2007
Accelr8 Announces Sale of Two New Licenses for OptiChem® Surface Coatings

NanoString acquires license for use with innovative molecular detection, and Schott acquires additional microarraying license.

October 18, 2007
Accelr8 Announces Patent Allowance for Rapid Bacterial Diagnostic Method

New Patent Supports BACcel® Rapid Analysis of “Superbugs” – Multiple Drug Resistant Bacteria

August 27, 2007
Accelr8 Reports New Benchmark
for Measuring Bacterial Growth

High-resolution measurement enables rapid discrimination between live and dead organisms.

July 10, 2007
Accelr8 Announces Presentation for Rapid Identification of Acinetobacter “Superbug” – Cause of Outbreaks of Serious Infections in Hospitals and for Wounded Soldiers

Acceptance joins an additional presentation for a major scientific meeting and an additional publication in a leading research journal.

June 15, 2007
Accelr8 Announces Reduced Losses, and Presentation of Results for Rapid MRSA Identification at ASM's 107^th General Meeting

New results with rapid test to identify MRSA “superbug” presented at major scientific meeting.

March 20, 2007
Accelr8 Announces Reduced Losses While Focusing on Rapid MRSA Identification in Hospital Acquired Infections

Product effort shifts to BACcel™-1.0 as test development progresses.

February 21, 2007
Accelr8 Announces Pilot Study Completion for Rapid MRSA Identification

Pilot study and scientific presentation to demonstrate results for rapid identification of major antibiotic-resistant “Staph.”

February 20, 2007
Accelr8 Announces Second License To SCHOTT Nexterion

SCHOTT licenses OptiChem®-streptavidin coating for microarraying.